Zusammenfassung

• Objekte (1 geändert, 0 hinzugefügt, 0 gelöscht)
  • Wikiderm.EntryClass[0]

Details

Wikiderm.EntryClass[0]

Eintrag

...	...	@@ -65,45 +65,12 @@
65	65	(% class="Feature" %)Bsp:(%%) Mycoplasma pneumoniae, HIV
66	66
67	67	(% class="Eintrag-2" %)
68		-(% class="Feature" %)DD:(%%) (% class="Bullet" %)-(%%) (% class="Abbreviation" %)AGEP(%%)
	68	+(% class="Feature" %)DD:(%%) (% class="Abbreviation" %)AGEP(%%), Dermatitis herpetiformis, eosinophile pustulöse Follikulitis Ofuji, Impetigo contagiosa, Pemphigus foliaceus, Psoriasis pustulosa
69	69
70		-(% class="Ebene-1" %)
71		-(% class="Bullet" %)-(%%) Dermatitis herpetiformis
72		-
73		-(% class="Ebene-1" %)
74		-(% class="Bullet" %)-(%%) eosinophile pustulöse Follikulitis Ofuji
75		-
76		-(% class="Ebene-1" %)
77		-(% class="Bullet" %)-(%%) Impetigo contagiosa
78		-
79		-(% class="Ebene-1" %)
80		-(% class="Bullet" %)-(%%) Pemphigus foliaceus
81		-
82	82	(% class="Eintrag-2" %)
	71	+(% class="Feature" %)Lit:(%%) {{pdfbox Datei="Varia, Pustulosis subcornealis Sneddon-Wilkinson, Arch Inflamm, 2016.pdf" /}}
83	83
84		-
85		-(% class="Ebene-1" %)
86		-(% class="Bullet" %)-(%%) Psoriasis pustulosa
87		-
88		-(% class="Ebene-1" %)
89		-(% class="Bullet" %)-(%%) Tinea incognito
90		-
91		-(% class="Ebene-2" %)
92		-(% class="Feature" %)Lit:(%%) [[Kalkan, G., Demirseren, D. D, Güney, C. A, & Aktaş, A. (2020). A case of tinea incognito mimicking subcorneal pustular dermatosis. Dermatology Online Journal, 26(2)>>url:https://escholarship.org/uc/item/46g9x55w]]
93		-
94	94	(% class="Eintrag-2" %)
95		-(% class="Feature" %)Lit:(%%) (% class="Bullet" %)-(%%) {{pdfbox Datei="Varia, Pustulosis subcornealis Sneddon-Wilkinson, Arch Inflamm, 2016.pdf" /}}
96		-
97		-(% class="Ebene-1" %)
98		-(% class="Bullet" %)-(%%) Open Access Maced J Med Sci. 2020 Jun 05; 8(T1):12-15. [[https:~~/~~/doi.org/10.3889/oamjms.2020.4870>>url:https://doi.org/10.3889/oamjms.2020.4870]]
99		-
100		-(% class="Ebene-1" %)
101		-(% class="Bullet" %)-(%%) International Journal of Women's Dermatology, Volume 6, Issue 3, 2020, Pages 131-136, ISSN 2352-6475, [[https:~~/~~/doi.org/10.1016/j.ijwd.2020.02.003>>url:https://doi.org/10.1016/j.ijwd.2020.02.003]]
102		-
103		-(% class="Ebene-1" %)
104		-(% class="Bullet" %)-(%%) SAGE Open Med Case Rep. 2019 Jan 30;7:2050313X19826432. [[http:~~/~~/doi.org/10.1177/2050313X19826432>>url:http://doi.org/10.1177/2050313X19826432]]
105		-
106		-(% class="Eintrag-2" %)
107	107	(% class="Feature" %)Th:(%%) (% class="Bullet" %)-(%%) lokal
108	108
109	109	(% class="Ebene-2" %)
...	...	@@ -188,9 +188,7 @@
188	188	(% class="Feature" %)Stoff:(%%) (% class="Bullet" %)-(%%) **[[Infliximab]]**
189	189
190	190	(% class="Ebene-4" %)
191		-{{pharMacro style="Ebene-4"}}
192	192	(% class="Feature" %)Phar:(%%) Remicade^^®^^
193		-{{/pharMacro}}
194	194
195	195	(% class="Ebene-4" %)
196	196	(% class="Feature" %)Dos:(%%) 5 mg/kg i.v.
...	...	@@ -205,11 +205,4 @@
205	205	(% class="Feature" %)Lit:(%%) Ann Dermatol Venereol. 2013 Dec;140(12):797-800 (Frankreich)
206	206
207	207	(% class="Ebene-5" %)
208		-(% class="Feature" %)PT:(%%) (% class="Abbreviation" %)CR(%%)
209		-
210		-(% class="Ebene-2" %)
211		-(% class="Bullet" %)-(%%) Guselkumab
212		-
213		-(% class="Ebene-3" %)
214		-(% class="Feature" %)Lit:(%%) Int J Dermatol. 2021 Apr;60(4):e153-e154. [[http:~~/~~/doi.org/10.1111/ijd.15311>>url:http://doi.org/10.1111/ijd.15311]]
215		-
	173	+(% class="Feature" %)PT:(%%) CR